Most Clicked StoriesMore >


Basaglar insulin injection gains tentative OK from FDA

DiabetesPro SmartBrief | Aug 19, 2014

Eli Lilly and Co. and Boehringer Ingelheim received tentative approval for the Basaglar insulin injection to boost blood glucose control in patients with diabetes. Reuters (08/19)


Fewer hypoglycemia events seen with new glargine formulation

DiabetesPro SmartBrief | Aug 15, 2014

Experts ID mechanism behind diabetes onset

DiabetesPro SmartBrief | Aug 21, 2014

Cholesterol drug lowers heart risk in diabetes patients

DiabetesPro SmartBrief | Aug 19, 2014

Reducing Cardiometabolic Risk: Patient Education Toolkit

DiabetesPro SmartBrief | Aug 19, 2014

Reduced inflammation seen with diet, exercise intervention

DiabetesPro SmartBrief | Aug 18, 2014

Diabetes patients who lose weight show lower kidney risk

DiabetesPro SmartBrief | Aug 21, 2014

FDA OKs Philosys' smartphone-based blood glucose monitor

DiabetesPro SmartBrief | Aug 20, 2014

Race, disease duration linked to eye trouble in diabetes

DiabetesPro SmartBrief | Aug 18, 2014

Persistent pancreatic cancer risk seen for decades with diabetes

DiabetesPro SmartBrief | Aug 21, 2014


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


Free CME/CE opportunity: Webcasts from Diabetes is Primary

DiabetesPro SmartBrief | Aug 22, 2014

Become a recognized education program through the American Diabetes Association

DiabetesPro SmartBrief | Aug 21, 2014

Performance improvement continuing education opportunity!

DiabetesPro SmartBrief | Aug 20, 2014

Reducing Cardiometabolic Risk: Patient Education Toolkit

DiabetesPro SmartBrief | Aug 19, 2014

Free CME/CE Opportunity -- Self-Assessment Program on the Management of Diabetes in a Camp Setting

DiabetesPro SmartBrief | Aug 18, 2014




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


What type of continuing education opportunities do you participate in most?

Chart.